conference reporter

63rd ASH Annual Meeting and Exposition

Conference Reporter in Chronic Myeloid Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter will feature coverage of selected topics in Chronic Myeloid Leukemia presented at this year’s ASH Annual Meeting.

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators:

Jorge E. Cortes, MD

Director, Georgia Cancer Center
Professor of Medicine
Augusta University
Augusta, GA

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Institute Physician
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA

Elias Jabbour, MD

Professor of Medicine, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX


Community-Selected Topics:

    Molecular Status for Discontinuation of Tyrosine Kinase Inhibitor Therapy
    Resistance and Persistence in Chronic Myeloid Leukemia
    Important Frontiers and Active Research Areas in Chronic Myeloid Leukemia
    COVID-19 in Chronic Myeloid Leukemia and Other Hematologic Malignancies
    Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Real-World Data
    Updates on Next-Generation Sequencing in Chronic Myeloid Leukemia


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Hematology. 

More in CML

Thumb

CML

Important Frontiers in Chronic Myeloid Leukemia Research

Conference Reporter by Daniel J. DeAngelo, MD, PhD

At the 63rd ASH Annual Meeting and Exposition, several presentations on chronic-phase chronic myeloid leukemia (CP-CML) provided data that may add ...READ MORE

Thumb

CML

Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Real-World Data

Conference Reporter by Daniel J. DeAngelo, MD, PhD

At the 63rd ASH Annual Meeting and Exposition, patterns of care in chronic myeloid leukemia (CML) were explored using real-world analyses. The data...READ MORE

Thumb

CML

Unmet Needs in Chronic Myeloid Leukemia and Insights From Next-Generation Studies

Conference Reporter by Elias Jabbour, MD

As reflected in data presented at the 63rd ASH Annual Meeting and Exposition, efforts are underway to refine current approaches to the management o...READ MORE

More In Conference Reporter